gallium-ga-68-dotatate and Esthesioneuroblastoma--Olfactory

gallium-ga-68-dotatate has been researched along with Esthesioneuroblastoma--Olfactory* in 2 studies

Other Studies

2 other study(ies) available for gallium-ga-68-dotatate and Esthesioneuroblastoma--Olfactory

ArticleYear
68Ga-DOTATOC PET/CT and MR in the Evaluation of Meningeal Metastasis From Esthesioneuroblastoma: A Case Report.
    Clinical nuclear medicine, 2021, Jul-01, Volume: 46, Issue:7

    Esthesioneuroblastoma is a rare malignant tumor arising from olfactory neuroepithelium. PET/CT with different tracers such as 18F-FDG and 68Ga-somatostatin-receptor tracers has demonstrated its utility for the evaluation of disease. We present the case of a woman previously treated for esthesioneuroblastoma performing MR and 18Ga-DOTATOC PET/CT demonstrating dural metastasis of disease with a strong correspondence between conventional and functional imaging.

    Topics: Esthesioneuroblastoma, Olfactory; Female; Humans; Meningeal Carcinomatosis; Middle Aged; Nasal Cavity; Nose Neoplasms; Organometallic Compounds; Positron Emission Tomography Computed Tomography

2021
68Ga-DOTATATE and 18F-FDG PET/CT for the Management of Esthesioneuroblastoma of the Sphenoclival Region.
    Clinical nuclear medicine, 2020, Volume: 45, Issue:8

    We present a 48-year-old woman with an olfactory neuroblastoma who was referred for accurate staging using PET/CT. The Ga-DOTATATE PET/CT showed a 51 × 32-mm mass with an SUVmax of 7.59 in the sphenoidal sinuses, whereas radiotracer uptake on F-FDG PET/CT was similar to that of brain tissue. Ga-DOTATATE PET/CT might be especially useful in regions with difficult tumor visualization resulting from high background, such as brain tissue. The results of this case may suggest that somatostatin receptor imaging in patients with esthesioneuroblastoma may facilitate the potential application of radiotheranostic agents for the treatment of this aggressive subtype of tumors.

    Topics: Esthesioneuroblastoma, Olfactory; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Nasal Cavity; Nose Neoplasms; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Receptors, Somatostatin

2020